Drug
N,N''-sulfonylbis-urea clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 4
- first study started
- 2000
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 4
- Phase 4
- 4
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 7
Haukeland University Hospital (3) · GlaxoSmithKline (2) · Tanabe Pharma Corporation (1) · University of Dundee (1) · Takeda (1) · University of Pittsburgh (1) · PhaseBio Pharmaceuticals Inc. (1) · University Hospital, Gentofte, Copenhagen (1)
Often tested with
Tested in the same studies.
Sulfonylurea Antidiabetic Agent (12) · Metformin (3) · Biguanides (2) · Teneligliptin (1) · Dipeptidyl-Peptidase IV Inhibitors (1) · Pioglitazone (1) · 2,4-thiazolidinedione (1) · Glycoside Hydrolase Inhibitors (1)
Studies
Open first, then newest update. How each study uses N,N''-sulfonylbis-urea is read from its arms, and is right about nine times in ten.
Testing it · 12
- Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic PatientsCompletedPhase 3Tanabe Pharma CorporationNCT02314637Written as Teneligliptin + Sulfonylurea
- Study of Sulphonylurea Synergy With DPP4 InhibitorsCompletedNot applicableUniversity of DundeeNCT04192292Written as Sulfonylurea
- Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)Status unknownPhase 4Haukeland University HospitalNCT02624830Written as Sulfonylurea
- Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY GenesStatus unknownPhase 4Haukeland University HospitalNCT04239586Written as Sulfonylurea
- Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyCompletedPhase 4TakedaNCT01972724Written as Sulfonylurea
- Long-Term Sulfonylurea Response in KCNJ11 Neonatal DiabetesCompletedPhase 4Haukeland University HospitalNCT02624817Written as Sulfonylurea
- A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes MellitusCompletedPhase 3GlaxoSmithKlineNCT01777282Written as Sulfonylurea
- RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesCompletedPhase 3GlaxoSmithKlineNCT00379769Written as Sulfonylurea
- Bypass Angioplasty Revascularization Investigation in Type 2 DiabetesCompletedPhase 3University of PittsburghNCT00006305Written as Insulin, sulfonylurea
- Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DMCompletedPhase 2PhaseBio Pharmaceuticals Inc.NCT01658501Written as Sulfonylurea
- The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 DiabetesCompletedPhase 2University Hospital, Gentofte, CopenhagenNCT00321321Written as Sulfonylurea
- Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 MutationsCompletedNot applicableRoyal Devon and Exeter NHS Foundation TrustNCT00334711Written as Sulfonylurea
Given in every arm · 9 — N,N''-sulfonylbis-urea is usual care beside what is tested
- A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic PatientsCompletedPhase 3Astellas Pharma IncNCT01242215Written as Sulfonylurea
- Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without SulfonylureaTerminatedPhase 3SanofiNCT03761134Written as sulfonylurea
- A Study of LY2409021 in Participants With Type 2 Diabetes MellitusTerminatedPhase 2Eli Lilly and CompanyNCT02111096Written as Sulfonylurea
- A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in TurkeyCompletedPhase 4SanofiNCT02954692Written as sulfonylurea
- A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)CompletedPhase 3Merck Sharp & Dohme LLCNCT02532855Written as Sulfonylurea
- Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00395746Written as sulfonylurea
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of SulfonylureaCompletedPhase 3SanofiNCT00713830Written as Sulfonylurea
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by MetforminCompletedPhase 3SanofiNCT01169779Written as Sulfonylurea
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)CompletedPhase 3SanofiNCT00866658Written as Sulfonylurea
As the comparator · 5 — what is tested is compared with N,N''-sulfonylbis-urea
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)CompletedPhase 4Merck Sharp & Dohme LLCNCT01131182Written as Comparator: Sulfonylurea
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During RamadanCompletedPhase 4SanofiNCT02941367Written as Sulfonylurea
- Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and SulfonylureasCompletedPhase 4Changhua Christian HospitalNCT03983551Written as Sulfonylurea
- Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)CompletedPhase 3Merck Sharp & Dohme LLCNCT01340768Written as Sulfonylurea
- Vildagliptin/Metformin in T2DM Patients Starting Basal InsulinCompletedPhase 3Novartis PharmaceuticalsNCT01871558Written as sulfonylurea (SU)
Codes
What other systems call N,N''-sulfonylbis-urea · ClinicalTrials.gg INT017243
- Wikidata Q27109921N,N''-sulfonylbis-ureaOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27109921 | N,N''-sulfonylbis-urea | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.